A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07344051 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07344051
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-05
- Primary completion
- 2027-09-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.